Loading organizations...
Developing novel antithrombotics derived from natural sources.
Bioxodes has raised $22.5M across 4 funding rounds.
Bioxodes has raised $22.5M in total across 4 funding rounds.
Bioxodes has raised $22.5M in total across 4 funding rounds.
Bioxodes's investors include Alain Parthoens, European Regional Development Fund, Walloon Region.
Bioxodes has raised $22.5M across 4 funding rounds. Most recently, it raised $6.4M Series A Extension in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 10, 2025 | $6.4M Series A Extension | Alain Parthoens | |
| Feb 12, 2025 | $3.1M Series A Extension | ||
| Nov 21, 2023 | $9.4M Series A | ||
| Nov 26, 2013 | $3.5M Seed | European Regional Development Fund, Walloon Region |